| Literature DB >> 30936878 |
Josué Díaz-Delgado1, Kátia R Groch1, Rodrigo Ressio2, Isis P J Riskallah2,3, Eva Sierra4, Simona Sacchini4, Óscar Quesada-Canales4, Manuel Arbelo4, Antonio Fernández4, Elitieri Santos-Neto5, Joana Ikeda5, Rafael Ramos de Carvalho5, Alexandre de Freitas Azevedo5, Jose Lailson-Brito5, Leonardo Flach6, Cristina T Kanamura2, Natália C C A Fernandes2, Bruno Cogliati3, Cinzia Centelleghe7, Sandro Mazzariol7, Ludovica Di Renzo8, Gabriella Di Francesco8, Giovanni Di Guardo9, José Luiz Catão-Dias1.
Abstract
Cetacean morbillivirus (CeMV; Paramyxoviridae) causes epizootic and interepizootic fatalities in odontocetes and mysticetes worldwide. Studies suggest there is different species-specific susceptibility to CeMV infection, with striped dolphins (Stenella coeruleoalba), bottlenose dolphins (Tursiops truncatus), and Guiana dolphins (Sotalia guianensis) ranking among the most susceptible cetacean hosts. The pathogenesis of CeMV infection is not fully resolved. Since no previous studies have evaluated the organ-specific immunopathogenetic features of CeMV infection in tissues from infected dolphins, this study was aimed at characterizing and comparing immunophenotypic profiles of local immune responses in lymphoid organs (lymph nodes, spleen), lung and CNS in CeMV-molecularly (RT-PCR)-positive cetaceans from Western Mediterranean, Northeast-Central, and Southwestern Atlantic. Immunohistochemical (IHC) analyses targeted molecules of immunologic interest: caspase 3, CD3, CD20, CD57, CD68, FoxP3, MHCII, Iba1, IFNγ, IgG, IL4, IL10, lysozyme, TGFβ, and PAX5. We detected consistent CeMV-associated inflammatory response patterns. Within CNS, inflammation was dominated by CD3+ (T cells), and CD20+ and PAX5+ (B cells) lymphocytes, accompanied by fewer Iba1+, CD68+, and lysozyme+ histiocytes, mainly in striped dolphins and bottlenose dolphins. Multicentric lymphoid depletion was characterized by reduced numbers of T cells and B cells, more pronounced in Guiana dolphins. Striped dolphins and bottlenose dolphins often had hyperplastic (regenerative) phenomena involving the aforementioned cell populations, particularly chronically infected animals. In the lung, there was mild to moderate increase in T cells, B cells, and histiocytes. Additionally, there was a generalized increased expression of caspase 3 in lymphoid, lung, and CNS tissues. Apoptosis, therefore, is believed to play a major role in generalized lymphoid depletion and likely overt immunosuppression during CeMV infection. No differences were detected regarding cytokine immunoreactivity in lymph nodes, spleen, and lung from infected and non-infected dolphins by semiquantitative analysis; however, there was striking immunoreactivity for IFNγ in the CNS of infected dolphins. These novel results set the basis for tissue-specific immunophenotypic responses during CeMV infection in three highly susceptible delphinid species. They also suggest a complex interplay between viral and host's immune factors, thereby contributing to gain valuable insights into similarities, and differences of CeMV infection's immunopathogenesis in relation to body tissues, CeMV strains, and cetacean hosts.Entities:
Keywords: Cetacean morbillivirus; apoptosis; cytokines; histiocytes; immunopathogenesis; lymphocytes; neuroimmunopathology
Year: 2019 PMID: 30936878 PMCID: PMC6431672 DOI: 10.3389/fimmu.2019.00485
Source DB: PubMed Journal: Front Immunol ISSN: 1664-3224 Impact factor: 7.561
Tested antigen, clone, species of origin, clonality, antigen retrieval methods, working dilutions for primary antibodies and amplification and visualization method for immunohistochemistry of selected immune components in formalin-fixed, paraffin-embedded lymphoid tissues of striped dolphins (Stenella coeruleoalba), bottlenose dolphins (Tursiops truncatus), and Guiana dolphins (Sotalia guianensis).
| Caspase 3 | Asp175 | Rabbit | Pol | pH6 | 1:200 | PoH/DAB |
| CD3 | A0452 | Rabbit | Pol | pH9 | 1:1000 | PoH/DAB |
| CD20 | RB9013P | Rabbit | Pol | pH9 | 1:100 | PoH/DAB |
| CD57 | NKNE1 | Mouse | Mon | pH6 | 1:400 | PoH/DAB |
| CD68 | KP1 | Mouse | Mon | pH6 | 1:3000 | PoH/DAB |
| FoxP3 | D2W8E | Mouse | Mon | pH9 | 1:10 | PoH/DAB |
| HLA-DRα | TAL1B5 | Mouse | Mon | pH9 | 1:400 | PoH/DAB |
| Iba-1 | NCNP24 | Rabbit | Pol | pH9 | 1:500 | PoH/DAB |
| IFNγ | DBNE1 | Mouse | Mon | pH6 | 1:1000 | PoH/DAB |
| IgG | A0423 | Rabbit | Pol | pH9 | 1:1000 | PoH/DAB |
| IL4 | ab9811 | Rabbit | Pol | pH9 | 1:400 | PoH/DAB |
| IL10 | ab34843 | Rabbit | Pol | pH9 | 1:400 | PoH/DAB |
| Lysozyme | A0099 | Rabbit | Pol | pH6 | 1:3000 | PoH/DAB |
| TGF-β | 213NE4.4 | Mouse | Mon | pH9 | 1:200 | PoH/DAB |
| PAX-5 | BC/24 | Mouse | Mon | pH9 | 1:300 | PoH/DAB |
CD, cluster of differentiation; FoxP3, Forkhead Box P3; HLA, human leukocyte antigen (synonym major histocompatibility complex); IFN, interferon; Ig, immunoglobulin; IL, interleukin; TGF, transforming growth factor; Pax-5, paired box 5; Mon, monoclonal; Pol, polyclonal; PK, proteinase K; NE: not evaluated; PoH; HiDef Detection™ Polymer System; DAB, Diaminobenzidine. Best antigen retrieval and primary antibody concentrations are indicated in bold. pH6, citrate; pH9, EDTA, Ethylenediamine tetraacetic acid.
Cell signaling (Danvers, MA, USA),
Dako-Agilent (Santa Clara, CA, USA),
Thermo (Fremont, CA, USA),
Novocastra-Leica (Nussloch, Germany),
Wako Pure Chemical (Richmond, VA, USA),
Bio-Rad (Hercules, CA, USA),
Proteintech (Rosemont, IL, USA),
Biocare (Pacheco, CA, USA),
Cell Marque (Rocklin, CA, USA),
DAB, 3,3′-Diaminobenzidine (D-5637; Sigma, St. Louis, Missouri, USA).
Epidemiologic and biologic data of Guiana dolphins (Sotalia guianensis), striped dolphins (Stenella coeruleoalba), and bottlenose dolphins (Tursiops truncatus) included in this study.
| 1 | 09-Nov-2017 | 23°10′6″S; 44°20′82″W (BR) | 177 | Ad | Fe | Po | 2 | D | AS | |
| 2 | 14-Nov-2017 | 23°00′47″S; 44°26′32″W (BR) | 94 | Ca | Ma | Mo | 2 | D | AS | |
| 3 | 17-Dec-2017 | 22°56′27″S; 43°59′34″W (BR) | 164 | Ju | Ma | Mo | 3 | D | SS | |
| 4 | 17-Dec-2017 | 23°03′08″S; 44°04′13″W (BR) | 93 | Ca | Fe | Go | 3 | D | AS | |
| 5 | 23-Dec-2017 | 22°58′43″S; 43°57′46″W (BR) | 149 | Ju | Ma | Mo | 2 | D | AS | |
| 6 | 25-Dec-2017 | 23°00′11″S; 43°56′46″W (BR) | 125 | Ju | Ma | Po | 3 | D | AS | |
| 7 | 26-Dec-2017 | 22°59′49″S; 43°55′12″W (BR) | 188 | Ad | Fe | ND | 3 | D | AS | |
| 8 | 27-Dec-2017 | 22°56′47″S; 44°00′35″W (BR) | 176 | Ad | Ma | Mo | 3 | D | AS | |
| 9 | 27-Dec-2017 | 22°56′50″S; 44°02′16″W (BR) | 183 | Ad | Ma | Mo | 3 | D | AS | |
| 10 | 27-Dec-2017 | 23°01′08″S; 43°54′06″W (BR) | 186 | Ad | Ma | Po | 3 | D | AS | |
| 11 | 15-Jan-2018 | 22°56′45″S; 43°54′26″W (BR) | 130 | Ju | Fe | Po | 2 | D | SS | |
| 12 | 13-Nov-2002 | 28°9′2″N; 15°32′8″W (SP) | 224 | Ad | Ma | Go | 2 | A | CS | |
| 13 | 18-Jul-2005 | 29°7′41″N;13°27′58″W (SP) | 250 | Ju | Fe | Mo | 2 | A | SS | |
| 14 | 16-Aug-2005 | 28°0′24″N; 15°22′35″W (SP) | 168 | Ju | Fe | Go | 2 | A | AS | |
| 15 | 16-Apr-2007 | 28°33′28″N; 16°20′1″W (SP) | 195 | Ju | Ma | Po | 2 | D | AS | |
| 16 | 02-May-2008 | 28°29′53″N; 13°50′59″W (SP) | 194 | Ju | Fe | Po | 3 | D | BOFDI | |
| 17 | 22-Jan-2009 | 28°28′2″N; 13°51′37″W (SP) | 212 | Ad | Fe | Go | 2 | D | BOFDI | |
| 18 | 10-Feb-2011 | 28°54′18″N; 13°44′20″W (SP) | 215 | Ad | Fe | Go | 2 | D | CS | |
| 19 | 28-Apr-2012 | 28°55′57″N; 13°49′46″W (SP) | 203 | Ju | Ma | Mo | 2 | D | AS | |
| 20 | 04-Jul-2011 | 40°06′38.5″N 15°13′10.1″E (IT) | 205 | Ad | Ma | Mo | 3 | D | BOFDI | |
| 21 | 20-Oct-2013 | 40°54′15.4″N 14°01′47.3″E (IT) | NR | Ad | Ma | ND | 3 | D | AS | |
| 22 | 02-Feb-2013 | 40°38′04.6″N 14°49′47.3″E (IT) | NR | Ad | Fe | ND | 3 | D | CS | |
| 23 | 20-Mar-2013 | 43°09′48.9″N 10°32′20.9″E (IT) | 203 | Ju | Ma | ND | 2 | D | AS | |
| 24 | 05-Feb-2013 | 38°12′57.1″N 15°13′50.8″E (IT) | 202 | Ad | Ma | ND | 2 | D | CS | |
| 25 | 30-Jun-2011 | 41°37′32.6″N 12°27′18.2″E (IT) | 297 | Ad | Ma | Mo | 2 | A | SS | |
| 26 | 12-Oct-2017 | 42°28′05″N 14°13′27″E (IT) | 200 | Ad | Fe | Mo | 2 | D | AS | |
| 27 | 10-Nov-2017 | 42°10′37″N 14°41′33″E (IT) | 188 | Ju | Fe | Mo | 3 | D | SS | |
| 28 | 29-Apr-09 | 28.002990, −15.373500 (SP) | 105 | Ca | Fe | Go | 2 | D | Not infected | |
| 29 | 15-Oct-2008 | 44.006247, 12.662941 (IT) | 118 | Ca | Ma | Mo | 2 | D | Not infected | |
| 30 | 26-Nov-17 | 23°00′57″S; 43°55′23″W (BR) | 89 | Ca | Ma | Mo | 2 | D | Not infected |
CeMV-positive;
CeMV-negative; NR, not recorded; Ca, calf; Ju, juvenile; Ad, adult; Fe, female; Ma, male; NS, nutritional status; Po, poor; Mo, moderate; G, good; DC, decomposition code (2, fresh; 3, moderate autolysis); SC, stranding condition (A: alive; D: dead). AS, acute systemic; SS, subacute systemic, CS, chronic systemic; BOFDI, brain only form of DMV infection.
Summary of the results for selected immunomarkers in lymph nodes and spleen of striped dolphins (Stenella coeruleoalba), bottlenose dolphins (Tursiops truncatus), and Guiana dolphins (Sotalia guianensis) included in this study.
| 1 | LNs | ++/3 | +/3 | +/3 | –/0 | ++/2 | +/2 | ++/3 | +/3 | +/3 | +/3 | +/3 | +/2 | ++/3 | +/2 | +/2 |
| Spleen | +++/3 | +/3 | +/3 | +/3 | ++/3 | –/0 | +,++/3 | ++/3 | +/3 | ++/3 | +/2 | ++/2 | ++/3 | +/2 | +/2 | |
| 2 | LNS | ++/2 | +/3 | +,++/3 | –/0 | +,++/2 | +/2 | ++,+++/3 | +/3 | +/3 | +/3 | +/2 | +/2 | ++/3 | +/3 | +,++/2 |
| Spleen | +/2 | +/3 | +,++/3 | +/2 | +,++/2 | –/0 | ++/3 | ++/3 | +/2 | +/3 | +/3 | +/2 | ++/3 | +/3 | +,++/3 | |
| 3 | LNs | +/2 | +/3 | +/3 | +/3 | ++/3 | +/2 | +,++/3 | +/2 | ++/2 | +/3 | +/2 | +,++/2 | +,+++/3 | +/2 | +/2 |
| Spleen | +/2 | +/2 | +/3 | –/0 | +/2 | –/0 | +/3 | +,++/3 | +/2 | +/2 | +/3 | +/2 | ++/3 | +/3 | +/2 | |
| 4 | LNs | +++/2 | +/3 | +/3 | +/2 | +,++/2 | +/3 | ++,+++/3 | +,++/3 | +/2 | +/2 | +/2 | +/2 | ++,+++/3 | +/2 | +/2 |
| Spleen | +/2 | +/3 | +/3 | –/0 | +,++/2 | +/2 | ++/3 | ++/3 | NE | NE | NE | NE | +,++/3 | NE | +/2 | |
| 5 | LNs | +++/3 | ++/3 | +,++/3 | –/0 | +/2 | +/3 | ++/3 | +,++/3 | +/2 | +,++/3 | +,++/3 | +,++/2 | ++/3 | +/3 | +/3 |
| Spleen | +/2 | +/3 | +,++/3 | –/0 | ++/3 | +/2 | +,++/3 | +++/2 | +/3 | +,++/2 | +/2 | +,++/2 | ++,+++/3 | +/2 | +,++/2 | |
| 6 | LNs | +/2 | +/2 | +/3 | +/3 | +/3 | +/2 | ++/3 | ++/2 | +/2 | +/2 | +/2 | +/2 | +/3 | +/2 | +/2 |
| Spleen | +/2 | +/2 | +/3 | +/2 | +/3 | +/2 | +,++/3 | +,++/3 | –/0 | +/2 | +/2 | +/2 | ++/3 | +/2 | +/3 | |
| 7 | LNs | +/3 | +/3 | +/3 | NE | NE | +/2 | NE | +,++/3 | NE | NE | +/2 | +/2 | NE | NE | +/3 |
| Spleen | +/3 | +/2 | +/3 | NE | NE | +/2 | NE | +,++/3 | NE | NE | NE | NE | NE | NE | +/3 | |
| 8 | LNs | +/3 | +/3 | +/3 | +/2 | ++/3 | +/2 | +,++/3 | +/3 | +/3 | +/3 | +/3 | +/3 | +,++/3 | +/2 | +/3 |
| Spleen | ++/3 | +/3 | +/3 | +/2 | ++/3 | –/0 | ++/3 | +/3 | +/2 | +/2 | +/3 | +/2 | ++,+++/3 | +,++/2 | +/3 | |
| 9 | LNs | ++/3 | ++/3 | +,++/3 | +/3 | ++/3 | +/3 | ++/3 | +/3 | NE | +/3 | +/3 | NE | ++,+++/3 | NE | +/2 |
| Spleen | +/2 | ++/2 | +,++/3 | +/3 | ++/2 | +/3 | +/2 | +/3 | +/3 | +/3 | +/2 | +/2 | ++/3 | +/2 | +,++/2 | |
| 10 | LNs | +++/3 | ++/3 | +,++/3 | +/2 | ++/2 | +/3 | +,++/3 | +/3 | +/2 | +/3 | +/2 | +/3 | ++/3 | +/2 | +,++/2 |
| Spleen | +/2 | ++/3 | +/3 | +/2 | ++/3 | +/2 | +/3 | ++/2 | +/2 | +/3 | +,++/2 | +,++/2 | ++,+++/3 | +/2 | +/2 | |
| 11 | LNs | +/2 | +/3 | +/3 | +/2 | +/3 | +/2 | +/3 | +/3 | +3 | +,++/3 | +/3 | +/2 | ++/3 | +/2 | +/2 |
| Spleen | +/2 | +/3 | +/3 | –/0 | ++/3 | –/0 | +/3 | +,++/3 | +/3 | +,++/3 | +/2 | +,++/3 | +/3 | +,++/2 | +/2 | |
| 12 | LNs | +/3 | ++,+++/3 | +,++/3 | +/3 | +,++/2 | +/3 | ++/3 | ++,+++/3 | +/3 | ++,+++/3 | +/3 | +/2 | +,++/3 | +/3 | +,++/3 |
| Spleen | ++/2 | ++/2 | ++/3 | +/3 | +,++/3 | +/3 | ++,+++/2 | ++,+++/3 | +,++/3 | +,++/3 | +/2 | +/3 | ++/3 | +/2 | +/3 | |
| 13 | LNs | ++/3 | +/3 | +,++/3 | +/3 | ++/2 | +/3 | ++,+++/3 | ++,+++/3 | +/3 | ++/3 | +/2 | +/3 | +,++/3 | +/2 | +/2 |
| Spleen | ++/2 | +/3 | +/3 | +/2 | +,++/3 | +/3 | ++/3 | ++,+++/3 | +/3 | ++/3 | +/3 | +/3 | ++/3 | +/3 | +/2 | |
| 14 | LNs | +++/2 | +++/2 | ++/3 | +/2 | +,++/2 | +/3 | ++,+++/3 | ++,+++/3 | +/3 | +/2 | +/2 | +/2 | +,++/3 | +/2 | ++/2 |
| Spleen | ++/3 | ++,+++/3 | ++/3 | +/2 | +,++/2 | +/3 | ++,+++/3 | ++,+++/3 | +/3 | +/3 | +/2 | +/2 | ++/3 | +/2 | ++/2 | |
| 15 | LNs | +++/3 | +,++/3 | +,++/3 | +/3 | ++/2 | +/3 | ++/3 | ++/3 | +,++/3 | +,++/3 | +/3 | +/3 | ++/2 | +,++/2 | +,++/2 |
| Spleen | +++/3 | ++/2 | ++/3 | +/3 | +/2 | +/3 | ++/3 | ++,+++/3 | +,++/3 | ++/3 | +/2 | +/3 | ++/2 | +/2 | ++/2 | |
| 16 | LNs | ++/3 | +/2 | +,++/3 | +,++/3 | +/3 | +/2 | +,++/3 | ++/3 | +,++/2 | ++/2 | +/2 | +/3 | +,++/2 | +/3 | +,++/2 |
| Spleen | ++/3 | ++/3 | +,++/3 | +/3 | +,++/2 | +/2 | +,++/3 | ++/3 | +/3 | +/3 | +/3 | +/2 | +/2 | +/2 | +,++/2 | |
| 17 | LNs | +++/3 | ++/3 | ++,+++/3 | +/3 | +,++/3 | +/3 | +,++/3 | ++/3 | +/3 | +,++/3 | +/3 | +/3 | +,++/3 | +/3 | +,+++/3 |
| Spleen | ++/3 | ++/3 | +,++/3 | –/0 | +,++/2 | +/3 | ++/3 | ++/3 | +/3 | ++/3 | +/3 | +/3 | +,++/3 | +/2 | +,++/3 | |
| 18 | LNs | ++/3 | ++/3 | +,++/3 | +/3 | +,++/2 | +/3 | ++/3 | ++/3 | +,++/3 | +/3 | +/3 | +/3 | ++/3 | +/2 | +,+++/3 |
| Spleen | ++/3 | ++,+++/3 | +,++/2 | +/2 | +/2 | +/3 | ++/3 | ++/3 | +/3 | +,++/3 | +/2 | +/2 | ++/2 | +/2 | +,+++/3 | |
| 19 | LNs | +++/2 | +++/2 | +,++/3 | ++/3 | ++3 | +/3 | ++,+++/3 | ++,+++/3 | +,++/3 | +/3 | +/3 | +,++/3 | ++,+++/3 | +/2 | ++/2 |
| Spleen | ++/2 | ++/3 | +/2 | +,++/3 | +,++/3 | +/3 | ++,+++/3 | ++,+++/3 | +/3 | +,++/3 | +/2 | ++/2 | ++/3 | +/2 | +/2 | |
| 20 | LNs | +/3 | +/3 | +,++/3 | +/2 | +,++/2 | –/0 | +,++/3 | ++/3 | NE | NE | NE | NE | NE | NE | +/2 |
| Spleen | +/3 | ++/2 | ++/3 | –/0 | +/2 | +/3 | +,++/3 | ++/2 | +/2 | +/2 | +/2 | +/2 | ++/3 | +/2 | +/2 | |
| 21 | LNs | ++/3 | ++/2 | ++/3 | +/2 | NE | +/3 | +,++/3 | ++/3 | NE | NE | NE | NE | NE | NE | ++/2 |
| Spleen | +++/3 | ++,+++/2 | ++,+++/3 | +/3 | ++/3 | +/2 | +,++/3 | +,++/3 | +/3 | +/3 | +,++/2 | +/3 | ++/3 | +,++/2 | ++/2 | |
| 22 | LNs | ++/3 | +++/3 | ++,+++/3 | +/2 | ++/2 | +/3 | ++/3 | +,++/2 | +/2 | ++,+++/3 | +/3 | +/2 | + to ++/3 | +/2 | ++,+++/3 |
| Spleen | ++/3 | ++/3 | ++,+++/3 | +/2 | +,++/2 | +/3 | ++/3 | +,++/2 | ++/3 | ++/3 | +/3 | +/2 | ++/3 | +/2 | ++/2 | |
| 23 | LNs | ++/2 | +++/2 | ++,+++/3 | +/3 | +/3 | +/2 | ++/2 | ++/3 | +/2 | +/2 | +/2 | +/3 | +/2 | ++/2 | |
| Spleen | ++/2 | ++/2 | ++/3 | +/2 | NE | +/2 | +,++/2 | ++,+++/2 | +,++/2 | +/2 | NE | NE | ++/3 | NE | ++/2 | |
| 24 | LNs | ++/2 | ++/3 | ++/3 | +/3 | ++,+++/2 | +/2 | +,++/3 | ++/3 | NE | +,++/2 | NE | NE | NE | ++/3 | |
| Spleen | ++/2 | ++/3 | ++/3 | +/3 | +,++/3 | +/3 | +,++/3 | +++/2 | +/3 | +,++/3 | +/3 | +/2 | ++/3 | +/3 | ++/3 | |
| 25 | LNs | ++/3 | ++,+++/3 | +,++/3 | +,++/3 | ++,+++/2 | +/3 | ++/3 | ++/2 | +,++/2 | ++/3 | ++/2 | +/3 | ++/+++/3 | +/3 | +,++/2 |
| Spleen | +++/3 | ++/2 | ++/3 | +/3 | ++,+++/3 | +/3 | ++/3 | ++/3 | +/2 | +/3 | +/2 | +/3 | ++/3 | +/2 | ++/2 | |
| 26 | LNs | +/3 | +/3 | +/3 | NE | NE | +/2 | ++/3 | ++/3 | NE | NE | NE | NE | NE | NE | +/3 |
| Spleen | +/3 | +/3 | ++/3 | NE | NE | +/2 | ++/3 | ++/3 | NE | NE | NE | NE | NE | NE | +/3 | |
| 27 | LNs | NE | NE | NE | NE | NE | NE | NE | NE | NE | NE | NE | NE | NE | NE | NE |
| Spleen | +/3 | +/3 | ++/3 | NE | NE | +/2 | ++/3 | ++,+++/3 | NE | NE | NE | NE | NE | NE | NE | |
| 28 | LNs | +/3 | ++,+++/3 | ++,+++/3 | +/3 | –/0 | +/3 | ++,+++/3 | ++,+++/3 | –/0 | +/2 | +/2 | +/2 | +/3 | –/0 | ++,+++/2 |
| Spleen | +/3 | ++/3 | ++,+++/3 | +/2 | +/2 | –/0 | +,++/3 | ++/2 | –/0 | +/2 | +/2 | +/2 | +/2 | +/2 | ++,+++/2 | |
| 29 | LNs | +/3 | ++,+++/3 | ++,+++/3 | ++/2 | –/0 | +/2 | ++,+++/3 | ++/3 | +/3 | +/2 | –/0 | +,++/2 | +/3 | +/2 | ++,+++/2 |
| Spleen | +/3 | ++/3 | ++,+++/3 | +/2 | –/0 | –/0 | +,++/3 | ++/3 | +/3 | +/2 | +/2 | +/2 | +/2 | +/2 | ++,+++/2 | |
| 30 | LNs | +/3 | ++,+++/3 | ++,+++/3 | +/2 | +/2 | +/3 | ++/3 | ++/3 | +/3 | +/2 | +/2 | +,++/2 | +/3 | +/3 | ++,+++/2 |
| Spleen | +/3 | ++/3 | ++,+++/3 | +/2 | +/2 | +/2 | ++,+++/3 | ++/3 | +/2 | +/2 | +/2 | +/2 | +/2 | +/2 | ++,+++/2 |
CD, cluster of differentiation; FoxP3, Forkhead Box P3; HLA, human leukocyte antigen (synonym major histocompatibility complex); IFN, interferon; Ig, immunoglobulin; IL, interleukin; TGF, transforming growth factor; Pax-5, paired box 5; NE, not evaluated. Semiquantitative analysis of immunopositive cells: –, no; +, <10%; ++, 10–50%; +++, 50–90%, and ++++, >90% immunopositive cells. Subjective labeling intensity score of immunopositive cells: 0, 1, 2, and 3.
Multisystemic hyphate mycosis (lung, kidney).
Hyphate mycosis (lung).
Suspect Brucella coinfection (primarily CNS lesions).
Sepsis by Staphylococcus aureus (particularly severe CNS and lung lesions).
Multisystemic hyphate mycosis (lung, cerebrum).
Figure 1Caspase 3 (CAS3) immunohistochemical findings. (A) Lymph node (case 22). Increased expression of CAS3 throughout the cortex. 100×. Inset: lymph node (case 22). Detail of increased CAS3 expression in mononuclear cells (MNCs) of mantle and paracortex. 400×. (B) Spleen (case 21). Increased expression of CAS3 throughout the white and red pulp. 100×. Inset: spleen (case 21). Detail of increased expression of CAS3 in white and red pulp. 400×. (C) Lung (case 18). Increased expression of CAS3 in proliferative and necrotizing bronchiolitis. 100×. Inset: lung (case 21). Detail of CAS3+ circulating MNCs in alveolar capillaries. 200×. (D) Cerebrum (case 24). Increased CAS3 expression in inflammatory cell infiltrates in Virchow-Robins space and adjacent neuroparenchyma. 400×. Inset: cerebrum (case 26). Detail of CAS3+ neurons, neuroglia, and infiltrating MNCs. 400×.
Figure 2Cluster of differentiation (CD)-3 immunohistochemical findings. (A) Lymph node (case 4). Markedly depleted CD3+ lymphocytes of cortex and paracortex. 100×. Inset: lymph node (case 22). CD3+ lymphocyte hyperplasia in paracortex (interfollicular). 400×. (B) Spleen (case 24). Reduced CD3+ lymphocytes through white pulp. 100×. Inset: spleen (case 17) CD3+ hyperplasia in white pulp and red pulp districts. 200×. (C) Lung (case 17). Mild, multifocal circulating and infiltrating CD3+ lymphocytes in alveolar walls and interstitium. 200×. Inset: lung (case 25). Marked CD3+ lymphocyte bronchiolar hyperplasia. 100×. (D) Cerebrum (case 24). Multiple Virchow-Robin spaces are expanded by CD3+ lymphocytes, which also infiltrate the adjacent parenchyma. 40×. Inset: cerebrum (case 24). Detail of abundant CD3+ lymphocytes perivascular and neuroparenchymal infiltration. 400×.
Figure 3Cluster of differentiation (CD)-20 immunohistochemical findings. (A) Lymph node (case 18). Moderate depletion of CD20 lymphocytes in cortical areas. 40×. Upper inset: lymph node (case 22). CD20+ lymphocyte hyperplasia. 40×. Lower inset: lymph node (case 18). CD20+ lymphocyte hyperplasia in medullary cords. 400×. (B) Spleen (case 21). Mild to moderate multifocal CD20-expressing lymphocyte depletion in white pulp. 40×. Inset: spleen (case 21). Detail of relatively normal CD20+ lymphocyte number in follicle. (C) Lung (case 13). Multifocal parabronchiolar, interstitial/alveolar septa CD20+ lymphocytic infiltrates. 100×. Inset: lung (case 25). Marked, multifocal peribronchiolar CD20+ lymphocytic infiltrates. 100×. (D) Spinal cord (case 13). Marked CD20+ leptomeningeal infiltration. 40×. Inset: cerebrum (case 26). Subpial CD20 perivascular and leptomeningeal CD20+ infiltrates. 400×.
Figure 4Paired box protein (PAX)-5 immunohistochemical findings. (A) Lymph node (case 17). Mild to moderate PAX5+ lymphocyte depletion in cortical area. 100×. Left inset: lymph node (case 17). Detail of mild PAX5+ lymphocyte depletion in follicle. 400×. Right inset: lymph node (case 18). PAX5+ lymphocyte hyperplasia in medullary cord. 400×. (B) Spleen (case 17). Mild PAX5+ lymphocyte follicular depletion. 200×. (C) Lung (case 18). Increased numbers of PAX5+ lymphocytes in lung interstitium. 400×. (D) Cerebrum (case 13). Moderate infiltration of PAX5 lymphocytes in leptomeninges. 200×. Inset: cerebrum (case 13). Detail of leptomeningeal infiltrating PAX5+ lymphocytes. 400×.
Figure 5Major histocompatibility (MHC) class II immunohistochemical findings. (A) Lymph node (case 12). MHCII expression in cortical cell elements mainly B-cell areas and sinuses. 100×. (B) Spleen (case 2). MHCII expression mostly in white pulp cell elements and red pulp. 100×. (C) Lung (case 9). Increased expression of MHCII in inflamed alveolus and exudative cells including reactive and binucleated histiocytes and syncytia. 400×. Inset: lung (case 12). Abundant MHCII-expressing inflammatory cells in inflamed distal bronchus. 100×. (D) Spinal cord (case 13). Overexpression of MHCII in spinal nerve root cell elements and infiltrating inflammatory cells. 200×. Inset: cerebrum (case 18). Overexpression of MHCII in perivascular inflammatory cells and vascular and neuroparenchymal cell elements. 200×.
Figure 6Ionized calcium binding adaptor molecule (Iba)-1 immunohistochemical findings. (A) Lymph node (case 17). Small to moderate amounts of Iba1-expressing histiocytes (including intra- and interfollicular dendritic cells, and sinus histiocytes) in cortex/paracortex interface and medullary cords. 100×. Upper inset: lymph node (case 17). Detail of Iba1+ follicular dendritic cells. 400×. Lower inset: lymph node (case 18). Detail of Iba1-expressing sinus histiocytes and hyperplastic medullary cords. 400×. (B) Spleen (case 15). Abundant expression of Iba1+ in histiocytic populations in red and white pulp. 100×. Inset: spleen (case 15). Detail of Iba1-expressing histiocytic cells in follicle and perifollicular zone. 400×. (C) Lung (case 19). Striking alveolar Iba1+ histiocytic inflammatory response including reactive, binucleated, and multinucleate macrophages/syncytia. 400×. (D) Cerebellum (case 25). Marked infiltration of Iba1+ histiocytes in interfoliar leptomeninges. 100×. Upper inset: cerebellum (case 25). Detail of Iba+ meningeal inflammatory infiltrate. 400×. Lower inset: prominent perivascular histiocytic infiltration including macrophages and microgliosis. 400×.
Figure 7Cluster of differentiation (CD)-68 immunohistochemical findings. (A) Lymph node (case 25). Detail of CD68+ follicular and interfollicular dendritic (histiocytes) cells. 400×. (B) Spleen (case 25). Abundant sinus histiocytic cells expressing CD68. 100×. Inset: spleen (case 25). Detail of perifollicular CD68+ histiocytic cells. 400×. (C) Lung (case 25). Abundant intrabronchiolar and intraalveolar histiocytes express CD68. Inset: lung (case 25). Detail of intraalveolar histiocytes expressing CD68. 400×. (D) Cerebellum (case 25). Detail of CD68+ histiocytes infiltrating the leptomeninges. 400×.
Figure 8Lysozyme immunohistochemical findings. (A) Lymph node (case 25). Lysozyme+ histiocytic cells in cortical and paracortical area. 200×. Inset: lymph node (case 25). Abundant intrasinus lysozyme-expressing histiocytes. 200×. (B) Spleen (case 14). Lysozyme+ histiocytes through the red pulp. 40×. Inset: spleen (case 14). Detail of lysozyme histiocytes in red pulp. 400×. (C) Lung (case 11). Overexpression of lysozyme by inflammatory cells and exudate in inflamed bronchioles and alveoli associated with CeMV and concomitant verminous pneumonia. 40×. Upper inset: lung (case 13). Circulating MNCs (including presumed pulmonary intravascular macrophages) are lysozyme+. 400×. Lower inset: lung (case 21). Increased lysozyme+ (mainly histiocytes) cells within inflammatory focus. 400×. (D) Spinal cord (case 13). Moderate number of lysozyme+ histiocytes in spinal cord leptomeninges. 100×. Inset: spinal cord (case 13). Detail of lysozyme+ histiocytic meningeal infiltrate. 400×.
Figure 9IgG immunohistochemical findings. (A) Lymph node (case 18). Scattered IgG+ cells in follicular and parafollicular areas. 200×. Left inset: lymph node (case 15). Increased IgG-expressing cells in follicular and parafollicular areas. 200×. Right inset: lymph node (case 12). IgG+ cell hyperplasia in medullary cord. 400×. (B) Spleen (case 13). Scattered IgG+ cells at white/red pulp interface. 200×. Inset: spleen (case 17). Increased IgG+ cells in white/red pulp interface. 400×. (C) Lung (case 12). IgG+ cells in hyperplastic BALT of inflamed bronchiole. 400×. (D) Cerebrum (case 14). Scattered IgG+ cells in leptomeninges. 400×. Inset: cerebrum (case 14). Detail of IgG+ cells in meningeal infiltrates. 400×.
Figure 10Interferon (IFN)-γ immunohistochemical findings. (A) Lymph node (case 17). Scattered MNCs including lymphocytes and histiocytes express IFNγ in cortex, paracortex and subcapsular/marginal sinus (square). Right inset: lymph node (case 17). IFNγ-expressing histiocyte within subcapsular/marginal sinus. 400×. Left inset: lymph node (case 17). Moderate number of IFNγ-expressing histiocytes and lymphocytes within paracortical/medullary sinuses. (B) Spleen (case 22). Scattered IFNγ-expressing cells in white and red pulp. Detail of IFNγ-expressing cells. 100×. Inset: 22. 400×. (C) Lung (case 23). IFNγ-expressing cells mainly include alveolar macrophages and scattered interstitial mononuclear cells. 100×. Inset: lung (case 23). Detail of IFNγ-expressing cells within perialveolar lymphocytic aggregate and rare alveolar macrophage. 400×. (D) Cerebrum (case 9). Meningeal and neuroparenchymal IFNγ-expressing cells. 400×.
Summary of results for selected immunomarkers in lung of Guiana dolphins (Sotalia guianensis), striped dolphins (Stenella coeruleoalba), and bottlenose dolphins (Tursiops truncatus) included in this study.
| 1 | +/2 | +/2 | +/3 | –/0 | +/2 | –/0 | +/3 | +/3 | +/2 | +,++/3 | +/3 | +/2 | +/3 | +/2 | +/2 |
| 2 | +/2 | +/3 | +/3 | +/3 | +/3 | –/0 | +/3 | +/3 | +/3 | +,++/3 | +/3 | +/2 | +/3 | +/2 | +/2 |
| 3 | ++/2 | +/3 | +/3 | –/0 | ++/2 | +/2 | +,++/3 | +/3 | +,++/2 | +,++/3 | +/3 | +,++/2 | ++,+++/3 | +/2 | +/2 |
| 4 | +/2 | +/3 | +/3 | –/0 | ++/2 | –/0 | +/3 | +/3 | ++/3 | +/3 | +/3 | +/2 | +/3 | +/2 | +/2 |
| 5 | +/3 | +/3 | +/3 | –/0 | +/2 | +/2 | +/3 | ++/3 | +/3 | +/2 | +/2 | +,++/2 | ++/3 | +/2 | +/3 |
| 6 | +/2 | +/2 | +/3 | +/3 | +/3 | –/0 | +/3 | +/2 | +/2 | +/3 | +/2 | +/2 | +/3 | +/2 | +/2 |
| 7 | +/2 | +/3 | +/3 | +/2 | +/3 | +/2 | +/3 | +/2 | +/3 | +/2 | +/2 | +/2 | +/3 | +/2 | +/2 |
| 8 | +/2 | +/3 | +/3 | –/0 | +/3 | +/3 | +/2 | +/3 | +/3 | +,++/3 | +/2 | +/2 | +,++/3 | +/2 | +/2 |
| 9 | ++/3 | ++,+++/3 | +/3 | –/0 | +/3 | +/3 | ++/3 | ++/3 | +/2 | +,++/3 | +,++/2 | +,++/2 | +/3 | +/2 | +/2 |
| 10 | ++/2 | +/3 | +/3 | –/0 | +/3 | +/3 | +/3 | +/3 | +/2 | +/3 | +/2 | +/2 | ++/3 | +/2 | +/2 |
| 11 | ++/2 | +/2 | +/3 | –/0 | +/2 | +/2 | +/3 | ++/3 | +/3 | +/3 | +,++/2 | ++,+++/3 | ++,+++/3 | +/2 | +/2 |
| 12 | +/3 | +/3 | +,++/3 | +/3 | ++/3 | +/3 | +,+++/3 | ++/3 | +/3 | ++/3 | +/3 | +,++/3 | +/3 | +/3 | +/3 |
| 13 | ++/3 | +/2 | +,++/3 | –/0 | ++/3 | +/2 | +,++/3 | ++/3 | +/3 | +/3 | +/3 | ++,+++/3 | ++,+++/3 | ++/2 | |
| 14 | ++/3 | +/2 | +/2 | –/0 | +/3 | +/2 | +/3 | +,++/3 | +/3 | +/2 | +/2 | +/3 | +/3 | +/2 | +/2 |
| 15 | +/3 | +/3 | +,++/3 | +/3 | +/3 | +/3 | ++/3 | +,++/3 | +,++/3 | +,++/3 | +/3 | ++,+++/3 | ++/2 | +/2 | +/3 |
| 16 | ++/3 | ++/3 | +/3 | –/0 | +/3 | +/2 | +/3 | +,++/3 | +/3 | +/2 | +/2 | +/2 | +/3 | +/2 | +/3 |
| 17 | ++/3 | ++/3 | ++/3 | +/2 | +/3 | +/3 | +,++/3 | +,++/3 | +,++/3 | +/3 | +/3 | +,++/2 | +,++/2 | +/3 | +/2 |
| 18 | ++/3 | ++/3 | ++/3 | +/3 | ++/3 | +/3 | ++,+++/3 | ++/3 | +/3 | ++/3 | +/2 | +,++/3 | ++/3 | +/2 | +,++/3 |
| 19 | +++/3 | ++/3 | +,++/2 | +/2 | +/2 | +/3 | +,++/3 | ++++/3 | +++/3 | ++/3 | +,++/3 | ++,+++/2 | +,++/3 | +/3 | +/2 |
| 20 | +/3 | +/2 | +/3 | –/0 | +/2 | +/3 | +/3 | +,++/3 | +/3 | +/3 | +/3 | +/3 | +,++/3 | –/0 | +/2 |
| 21 | +/3 | +/3 | +/3 | +/2 | +/2 | +/2 | +/3 | +/3 | +/3 | +/3 | +/2 | +/3 | +,++/3 | +/2 | +/2 |
| 22 | ++/3 | +,++/3 | +/3 | +/2 | +/2 | +/2 | +,+++/3 | +/3 | +/2 | +/2 | +,++/2 | +/2 | +/3 | +/2 | +/3 |
| 23 | +/2 | +/3 | +/3 | +/2 | +/3 | +/2 | +,++/3 | +/3 | +,++/3 | +/3 | +/2 | +/3 | +/3 | +/2 | +/2 |
| 24 | +/3 | +/3 | +/3 | –/0 | +/3 | +/2 | +/3 | +/3 | +/2 | +/3 | +/3 | +/3 | +/3 | +/2 | +/2 |
| 25 | ++/3 | ++++/3 | ++,+++/3 | +/3 | ++,+++/3 | +/3 | +,++/3 | +/3 | +/3 | +,++/3 | ++,+++/2 | +/3 | ++,+++/3 | +/2 | +,++/3 |
| 26 | +/3 | +/3 | +/3 | NE | NE | NE | NE | +/3 | +/3 | +/3 | NE | NE | NE | NE | NE |
| 27 | +/3 | +/2 | +/3 | –/0 | +,++/3 | +/2 | +/2 | +/2 | +/2 | +/3 | +/2 | +/2 | +,++/3 | +/2 | +/2 |
| 28 | +/3 | +/3 | +/3 | –/0 | –/0 | –/0 | +/3 | +/3 | –/0 | –/0 | +/2 | +/2 | –/0 | –/0 | +/3 |
| 29 | +/3 | +/3 | +/3 | –/0 | –/0 | –/0 | +/3 | +/3 | +/3 | +/2 | +/2 | +,++/2 | –/0 | +/3 | +/3 |
| 30 | +/3 | +/3 | +/3 | –/0 | –/0 | –/0 | +/3 | +/3 | –/0 | +/2 | +/2 | +/2 | +/2 | +/2 | +/3 |
CD, cluster of differentiation; FoxP3, Forkhead Box P3; HLA, human leukocyte antigen (synonym major histocompatibility complex); IFN, interferon; Ig, immunoglobulin; IL, interleukin; TGF, transforming growth factor; Pax-5, paired box 5; NE, not evaluated. Semiquantitative analysis of immunopositive cells: –, no; +, <10%; ++, 10–50%; +++, 50–90%, and ++++, >90% immunopositive cells. Subjective labeling intensity score of immunopositive cells: 0, 1, 2, and 3.
Multisystemic hyphate mycosis (lung, kidney).
Hyphate mycosis (lung).
Suspect Brucella coinfection (primarily CNS lesions).
Sepsis by Staphylococcus aureus (particularly severe CNS and lung lesions).
Multisystemic hyphate mycosis (lung, cerebrum).
Summary of results for selected immunomarkers in cerebrum, cerebellum, brain stem, and spinal cord of Guiana dolphins (Sotalia guianensis), striped dolphins (Stenella coeruleoalba), and bottlenose dolphins (Tursiops truncatus) included in this study.
| 1 | +/2 | –/0 | –/0 | –/0 | –/0 | –/0 | +/3 | –/0 | +/3 | –/0 | –/0 | –/0 | +/3 | –/0 | –/0 |
| 2 | +/2 | –/0 | –/0 | –/0 | –/0 | –/0 | +/3 | +/2 | –/0 | –/0 | –/0 | –/0 | +/3 | –/0 | –/0 |
| 3 | +/3 | –/0 | –/0 | –/0 | –/0 | –/0 | +/3 | –/0 | –/0 | –/0 | –/0 | –/0 | –/0 | –/0 | –/0 |
| 4 | –/0 | –/0 | –/0 | –/0 | –/0 | –/0 | +/3 | +/2 | –/0 | –/0 | +/2 | –/0 | –/0 | –/0 | –/0 |
| 5 | –/0 | –/0 | –/0 | –/0 | –/0 | –/0 | +/3 | –/0 | –/0 | –/0 | –/0 | –/0 | +/3 | –/0 | –/0 |
| 6 | +/2 | –/0 | –/0 | –/0 | +/2 | –/0 | +/3 | +/3 | –/0 | –/0 | –/0 | –/0 | +/3 | –/0 | –/0 |
| 7 | +/3 | +/3 | –/0 | –/0 | –/0 | –/0 | +/3 | –/0 | +/3 | –/0 | +/2 | –/0 | +/2 | –/0 | –/0 |
| 8 | +/3 | –/0 | –/0 | –/0 | –/0 | –/0 | +/3 | –/0 | –/0 | –/0 | –/0 | –/0 | +/3 | –/0 | –/0 |
| 9 | +/2 | +/3 | –/0 | –/0 | –/0 | –/0 | +/3 | +/3 | +/3 | +/2 | –/0 | –/0 | +/3 | –/0 | –/0 |
| 10 | +/3 | +/3 | –/0 | –/0 | +/2 | –/0 | +/3 | +/3 | +/3 | –/0 | +/2 | –/0 | +/3 | –/0 | –/0 |
| 11 | +/2 | –/0 | –/0 | –/0 | +/2 | –/0 | +/3 | +/3 | –/0 | –/0 | –/0 | –/0 | +/3 | –/0 | –/0 |
| 12 | +/3 | ++/2 | +/2 | –/0 | +/2 | –/0 | +/2 | +/3 | +/3 | +/3 | –/0 | +/2 | +/3 | –/0 | +/2 |
| 13 | +/3 | ++/2 | ++,+++/3 | +/3 | +/2 | +/3 | +++/3 | ++,+++/3 | ++/3 | ++/3 | +/2 | –/0 | +,++/3 | –/0 | ++/3 |
| 14 | +/3 | ++/2 | +,++/2 | –/0 | +/2 | +/2 | ++/3 | +/3 | +/3 | +/3 | +/2 | +/3 | +/3 | –/0 | +/2 |
| 15 | +/2 | +/3 | +/3 | –/0 | +/2 | –/0 | ++/3 | +/3 | +/3 | +/3 | +/2 | –/0 | +/2 | –/0 | +/2 |
| 16 | +/2 | ++/2 | +/2 | –/0 | +/2 | –/0 | ++/3 | +/3 | +/2 | +/2 | +/2 | –/0 | +/3 | –/0 | +/2 |
| 17 | +/2 | ++/3 | +/2 | –/0 | +/2 | –/0 | ++/3 | +/3 | +/3 | +/3 | +/3 | –/0 | +/3 | –/0 | +/2 |
| 18 | +/2 | ++/3 | +,++/3 | –/0 | +/2 | –/0 | ++/3 | +,++/3 | +/2 | +/3 | +/3 | –/0 | +/3 | –/0 | +/2 |
| 19 | ++/3 | ++/3 | +,++/3 | –/0 | +/2 | –/0 | +++/3 | ++/3 | +/3 | +/2 | +/3 | +/2 | +/3 | –/0 | +/2 |
| 20 | +/2 | +/2 | +/2 | –/0 | –/0 | –/0 | +/3 | +/2 | +/2 | +/2 | +/3 | –/0 | +/2 | –/0 | –/0 |
| 21 | +/2 | +/3 | +/2 | –/0 | +/3 | –/0 | +/2 | +/3 | +,++/3 | –/0 | +/2 | –/0 | +/3 | –/0 | –/0 |
| 22 | +/2 | +/3 | +/3 | –/0 | +/2 | –/0 | +/2 | +/3 | +/3 | +/3 | –/0 | –/0 | +/2 | +/2 | +/2 |
| 23 | +/3 | +/3 | +/3 | –/0 | +/2 | –/0 | +/3 | +/2 | +/3 | +/2 | +/2 | –/0 | +/3 | –/0 | –/0 |
| 24 | +,++/3 | +++/3 | +/3 | –/0 | +/3 | –/0 | +,+++/3 | +/2 | +/3 | +/2 | +/2 | –/0 | +/3 | –/0 | +/2 |
| 25 | +,++/2 | +,+++/3 | ++/3 | +/3 | +/3 | –/0 | ++/3 | +,+++/3 | +/3 | +,++/3 | +/2 | +/3 | +,+++/3 | +/3 | +/2 |
| 26 | ++/3 | +++/3 | +/3 | +/3 | +/2 | –/0 | +,++/3 | ++/3 | +,++/2 | +/3 | +/2 | –/0 | +/3 | –/0 | +/2 |
| 27 | ++/3 | +/3 | +/2 | –/0 | +/2 | –/0 | +/3 | +/2 | –/0 | +/3 | +/3 | –/0 | +,++/3 | –/0 | –/0 |
| 28 | –/0 | –/0 | –/0 | –/0 | –/0 | –/0 | –/0 | –/0 | –/0 | –/0 | –/0 | –/0 | –/0 | –/0 | –/0 |
| 29 | –/0 | –/0 | –/0 | –/0 | –/0 | –/0 | –/0 | –/0 | –/0 | –/0 | –/0 | –/0 | –/0 | –/0 | –/0 |
| 30 | +/3 | –/0 | –/0 | –/0 | –/0 | –/0 | +/2 | –/0 | –/0 | –/0 | –/0 | –/0 | –/0 | –/0 | –/0 |
CD, cluster of differentiation; FoxP3, Forkhead Box P3; HLA, human leukocyte antigen (synonym major histocompatibility complex); IFN, interferon; Ig, immunoglobulin; IL, interleukin; TGF, transforming growth factor; Pax-5, paired box 5; NE, not evaluated. Semiquantitative analysis of immunopositive cells: –, no; +, <10%; ++, 10–50%; +++, 50–90%, and ++++, >90% immunopositive cells. Subjective labeling intensity score of immunopositive cells: 0, 1, 2, and 3.
Multisystemic hyphate mycosis (lung, kidney).
Hyphate mycosis (lung).
Suspect Brucella coinfection (primarily CNS lesions).
Sepsis by Staphylococcus aureus (particularly severe CNS and lung lesions).
Multisystemic hyphate mycosis (lung, cerebrum).